Our results indicated that STZ treatment induced an upregulation of the aforementioned gene with the elevation of the inflammatory markers (TNF-α, IL-1β, and IL-6), confirming the incidence of DM and inflammation. This evidence concerns the gene IL1B and diabetes mellitus.